Cite
Identification of 2-fluoro-8-methyl-11-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)-5H-dibenzo[b,e][1,4]diazepine with clozapine-like mixed activities at muscarinic acetylcholine, dopamine, and serotonin receptors.
MLA
Watanabe, Hitoshi, et al. “Identification of 2-Fluoro-8-Methyl-11-(1-Methyl-1,2,3,6-Tetrahydropyridin-4-Yl)-5H-Dibenzo[b,e][1,4]Diazepine with Clozapine-like Mixed Activities at Muscarinic Acetylcholine, Dopamine, and Serotonin Receptors.” Bioorganic & Medicinal Chemistry Letters, vol. 40, May 2021, p. 127911. EBSCOhost, https://doi.org/10.1016/j.bmcl.2021.127911.
APA
Watanabe, H., Ishida, K., Yamamoto, M., Nakako, T., Horiguchi, M., & Isobe, Y. (2021). Identification of 2-fluoro-8-methyl-11-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)-5H-dibenzo[b,e][1,4]diazepine with clozapine-like mixed activities at muscarinic acetylcholine, dopamine, and serotonin receptors. Bioorganic & Medicinal Chemistry Letters, 40, 127911. https://doi.org/10.1016/j.bmcl.2021.127911
Chicago
Watanabe, Hitoshi, Kyoji Ishida, Masanori Yamamoto, Tomokazu Nakako, Masakuni Horiguchi, and Yoshiaki Isobe. 2021. “Identification of 2-Fluoro-8-Methyl-11-(1-Methyl-1,2,3,6-Tetrahydropyridin-4-Yl)-5H-Dibenzo[b,e][1,4]Diazepine with Clozapine-like Mixed Activities at Muscarinic Acetylcholine, Dopamine, and Serotonin Receptors.” Bioorganic & Medicinal Chemistry Letters 40 (May): 127911. doi:10.1016/j.bmcl.2021.127911.